公开(公告)号：EP2324028A2

公开(公告)日：2011-05-25

申请号：EP09785441.8

申请日：2009-08-03

申请人： AstraZeneca AB

发明人： BENNETT, Stuart, Norman, Lile ,  BONN, Peter, Gustaf ,  BRINK, Mikael, Dan ,  BUTLIN, Roger, John ,  CAMPBELL, Leonie ,  DAVIES, Robert, Darren, Morse ,  FÄGERHAG, Jonas, Rickard ,  JURVA, Ulrik ,  POINTON, Helen, Claire ,  ROBB, Graeme, Richard ,  SCHNECKE, Volker ,  SVENSSON HENRIKSSON, Anette Marie ,  WALKER, Rolf, Peter ,  WARING, Michael, James ,  WESTERLUND, Christer, Ralf

IPC分类号： C07D487/04 ,  A61K31/519 ,  A61P3/04 ,  A61P3/10

CPC分类号： C07D487/04

摘要： A compound of Formula (I) is useful in the treatment or prevention of a disease or medical condition mediated through glucokinase (GLK or GK), leading to a decreased glucose threshold for insulin secretion.